The Effect of Krocina™ on Decreasing Substance User Withdrawal Syndrome, Craving, Depression and Stress: A Double-Blind Randomized Parallel Clinical Trial.

Hamid JomehpourShahrokh AghayanAhmad Khosravi Fahimeh Afzaljavan

Published in: Substance use & misuse (2022)

Our finding rejected the effectiveness of 30 mg/day of Krocina™ for six weeks as an effective substance for decreasing withdrawal symptoms, craving, depression, anxiety and stress at the detoxification period and abstinence phase.

Keyphrases

sleep quality
clinical trial
double blind
depressive symptoms
open label
phase ii
phase iii
randomized controlled trial
placebo controlled
stress induced
smoking cessation
study protocol
case report
physical activity
heat stress